ve transitional cell carcinoma of the urinary bladder. Int J Oncol. 23(1):41-48, 2003. 3. Varella-Garcia M, Akduman B, Sunpaweravong P, Di Maria MV, Crawford ED. The UroVysionT" fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer. Urol Oncol. 22(1):16-19,